ReviewAntibody therapeutics2025

Reprogramming the tumor microenvironment: synergistic mechanisms of antibody-drug conjugates and immune checkpoint inhibitors.

Ling Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.